These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6343536)
1. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases. España F; Ratnoff OD J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536 [TBL] [Abstract][Full Text] [Related]
2. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents. España F; Ratnoff OD J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770 [TBL] [Abstract][Full Text] [Related]
3. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid. Ratnoff OD; Saito H J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109 [TBL] [Abstract][Full Text] [Related]
4. Properties of sulfatides in factor-XII-dependent contact activation. Tans G; Griffin JH Blood; 1982 Jan; 59(1):69-75. PubMed ID: 6914902 [TBL] [Abstract][Full Text] [Related]
5. Initiation of contact activation by sulfatides. Tans G; Griffin JH Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4. Dumenco LL; Everson B; Culp LA; Ratnoff OD J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni. Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502 [TBL] [Abstract][Full Text] [Related]
8. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor). Schousboe I Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361 [TBL] [Abstract][Full Text] [Related]
9. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems. Saito H; Ratnoff OD J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996 [TBL] [Abstract][Full Text] [Related]
10. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. Weiss AS; Gallin JI; Kaplan AP J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577 [TBL] [Abstract][Full Text] [Related]
18. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor). Cochrane CG; Wuepper KD J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492 [TBL] [Abstract][Full Text] [Related]
19. Activation of factor XII and prekallikrein with cholesterol sulfate. Shimada T; Kato H; Iwanaga S; Iwamori M; Nagai Y Thromb Res; 1985 Apr; 38(1):21-31. PubMed ID: 3847226 [TBL] [Abstract][Full Text] [Related]
20. [Activation mechanism of bovine factor XII on foreign surfaces--activation by polysaccharide sulfate and sulfatide and inhibition by platelet components]. Kato H; Shimada T; Ohno Y; Sugo T; Kodama K Rinsho Byori; 1982 Jun; Suppl 50():102-13. PubMed ID: 6215509 [No Abstract] [Full Text] [Related] [Next] [New Search]